GLUT2 is a high affinity glucosamine transporter, FEBS Letters, vol.37, issue.1-3, pp.199-203, 2002. ,
DOI : 10.1016/S0014-5793(02)03058-2
Coordinated regulation of glutamine:fructose-6- phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation, J Biol Chem, vol.266, pp.10148-10154, 1991. ,
Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance, Diabetes, vol.49, issue.9, pp.1492-1499, 2000. ,
DOI : 10.2337/diabetes.49.9.1492
Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro, Osteoarthritis and Cartilage, vol.6, issue.6, pp.427-434, 1998. ,
DOI : 10.1053/joca.1998.0146
Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-??B pathway, FEBS Letters, vol.264, issue.3, pp.166-170, 2002. ,
DOI : 10.1016/S0014-5793(01)03255-0
Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta, Arthritis Research & Therapy, vol.8, issue.6, p.173, 2006. ,
DOI : 10.1186/ar2082
Glucosamine inhibits IL-1??-induced NF??B activation in human osteoarthritic chondrocytes, Osteoarthritis and Cartilage, vol.11, issue.4, pp.290-298, 2003. ,
DOI : 10.1016/S1063-4584(03)00028-1
Enhanced healing of cartilaginous injuries by glucosamine hydrochloride, Carbohydrate Polymers, vol.48, issue.4, pp.369-378, 2002. ,
DOI : 10.1016/S0144-8617(01)00281-8
Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants. Osteoarthritis Cartilage, pp.387-394, 2005. ,
Glucosamine Inhibits Inducible Nitric Oxide Synthesis, Biochemical and Biophysical Research Communications, vol.279, issue.1, pp.234-239, 2000. ,
DOI : 10.1006/bbrc.2000.3912
Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils, J Leukoc Biol, vol.71, pp.632-640, 2002. ,
Immunosuppressive Effects of Glucosamine, Journal of Biological Chemistry, vol.277, issue.42, pp.39343-39349, 2002. ,
DOI : 10.1074/jbc.M204924200
Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy, Food and Chemical Toxicology, vol.43, issue.2, pp.187-201, 2005. ,
DOI : 10.1016/j.fct.2004.11.006
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review, Arzneimittelforschung, vol.51, pp.699-725, 2001. ,
Pharmacokinetics of glucosamine in the dog and in man, Arzneimittelforschung, vol.36, pp.729-735, 1986. ,
Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee, Osteoarthritis and Cartilage, vol.2, issue.1, pp.61-69, 1994. ,
DOI : 10.1016/S1063-4584(05)80007-X
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial, The Lancet, vol.357, issue.9252, pp.251-256, 2001. ,
DOI : 10.1016/S0140-6736(00)03610-2
Glucosamine therapy for treating osteoarthritis, Cochrane Database Syst Rev, p.2946, 2005. ,
DOI : 10.1002/14651858.cd002946.pub2
Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis, Archives of Internal Medicine, vol.163, issue.13, pp.1514-1522, 2003. ,
DOI : 10.1001/archinte.163.13.1514
URL : https://hal.archives-ouvertes.fr/hal-00427347
Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis, New England Journal of Medicine, vol.354, issue.8, pp.795-808, 2006. ,
DOI : 10.1056/NEJMoa052771
Effect of Glucosamine Sulfate on Hip Osteoarthritis, Annals of Internal Medicine, vol.148, issue.4, pp.268-277, 2008. ,
DOI : 10.7326/0003-4819-148-4-200802190-00005
Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation, Arthritis & Rheumatism, vol.38, issue.4, pp.634-646, 1998. ,
DOI : 10.1002/1529-0131(199804)41:4<634::AID-ART10>3.0.CO;2-1
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage, pp.13-29, 2006. ,
Glucosamine and Chondroitin Sulfate as Therapeutic Agents for Knee and Hip Osteoarthritis, Drugs & Aging, vol.47, issue.1, pp.573-580, 2007. ,
DOI : 10.2165/00002512-200724070-00005
URL : http://orbi.ulg.ac.be/jspui/handle/2268/19999
GLUCOSAMINE IN THE TREATMENT OF OSTEOARTHRITIS, Rheumatic Disease Clinics of North America, vol.26, issue.1, pp.1-11, 2000. ,
DOI : 10.1016/S0889-857X(05)70116-2
Clinical review of chondroitin sulfate in osteoarthritis. Osteoarthritis Cartilage, pp.19-21, 2008. ,
Glucosamine sulphate: a controlled clinical investigation in arthrosis, Pharmatherapeutica, vol.2, pp.504-508, 1981. ,
Symptomatic treatment of osteoarthritis: paracetamol or NSAIDs?, International Journal of Clinical Practice, vol.8, issue.6, pp.5-12, 2004. ,
DOI : 10.1111/j.1742-1241.2004.005_b.x
Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum, pp.2267-2277, 2007. ,
Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury, Glia, vol.175, issue.Pt 5, pp.1881-1892, 2010. ,
DOI : 10.1002/glia.21058
The role of cytokines in osteoarthritis pathophysiology, Biorheology, vol.39, pp.237-246, 2002. ,
The Role of Cytokines in Cartilage Matrix Degeneration in Osteoarthritis, Clinical Orthopaedics and Related Research, vol.427, pp.27-36, 2004. ,
DOI : 10.1097/01.blo.0000144854.66565.8f
The molecular understanding of osteoclast differentiation, Bone, vol.40, issue.2, pp.251-264, 2007. ,
DOI : 10.1016/j.bone.2006.09.023
Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells, Bone, vol.41, issue.4, pp.592-602, 2007. ,
DOI : 10.1016/j.bone.2007.05.016
Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-??B Signaling Pathways, Journal of Biological Chemistry, vol.283, issue.17, pp.11535-11540, 2008. ,
DOI : 10.1074/jbc.M607999200
IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-??B Ligand, Osteoprotegerin, and Receptor Activator of NF-??B in Mouse Calvariae, The Journal of Immunology, vol.169, issue.6, pp.3353-3362, 2002. ,
DOI : 10.4049/jimmunol.169.6.3353
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation, Journal of Bone and Mineral Research, vol.152, issue.suppl, pp.88-95, 1996. ,
DOI : 10.1002/jbmr.5650110113
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-?? and IL-17, Rheumatology, vol.47, issue.11, pp.1635-1640, 2008. ,
DOI : 10.1093/rheumatology/ken363
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation, Cell, vol.93, issue.2, pp.165-176, 1998. ,
DOI : 10.1016/S0092-8674(00)81569-X
Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-??B Ligand, Journal of Biological Chemistry, vol.281, issue.48, pp.36846-36855, 2006. ,
DOI : 10.1074/jbc.M606656200
Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus, Endocrinology, vol.142, pp.1419-1426, 2001. ,
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, Nature, vol.402, pp.304-309, 1999. ,
Activated human T cells directly induce osteoclastogenesis from human monocytes: Possible role of T cells in bone destruction in rheumatoid arthritis patients, Arthritis & Rheumatism, vol.247, issue.5, pp.1003-1012, 2001. ,
DOI : 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#
Correlation between radiographically diagnosed osteophytes and magnetic resonance detected cartilage defects in the patellofemoral joint, Annals of the Rheumatic Diseases, vol.57, issue.7, pp.395-400, 1998. ,
DOI : 10.1136/ard.57.7.395
Osteophytes: relevance and biology. Osteoarthritis Cartilage, pp.237-244, 2007. ,
Differential effects of local application of BMP-2 or TGF-??1 on both articular cartilage composition and osteophyte formation, Osteoarthritis and Cartilage, vol.6, issue.5, pp.306-317, 1998. ,
DOI : 10.1053/joca.1998.0129
Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor ??-induced osteophytes: Limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation, Arthritis & Rheumatism, vol.52, issue.12, pp.4065-4073, 2007. ,
DOI : 10.1002/art.23034
Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease, Arthritis Research & Therapy, vol.10, issue.5, p.115, 2008. ,
DOI : 10.1186/ar2518
Expression of transforming growth factor-?? (TGF??) and the TGF?? signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation, Annals of the Rheumatic Diseases, vol.65, issue.11, pp.1414-1421, 2006. ,
DOI : 10.1136/ard.2005.045971
Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation, Developmental Cell, vol.8, issue.5, pp.751-764, 2005. ,
DOI : 10.1016/j.devcel.2005.02.017
Regulation of bone mass by Wnt signaling, Journal of Clinical Investigation, vol.116, issue.5, pp.1202-1209, 2006. ,
DOI : 10.1172/JCI28551
Wnt signalling in osteoblasts regulates expression of the receptor activator of NF??B ligand and inhibits osteoclastogenesis in vitro, Journal of Cell Science, vol.119, issue.7, pp.1283-1296, 2006. ,
DOI : 10.1242/jcs.02883
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia, Bone, vol.39, issue.4, pp.754-766, 2006. ,
DOI : 10.1016/j.bone.2006.03.017
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass, Journal of Bone and Mineral Research, vol.280, issue.6, pp.934-945, 2006. ,
DOI : 10.1359/jbmr.060311
Dickkopf-1 is a master regulator of joint remodeling, Nature Medicine, vol.19, issue.2, pp.156-163, 2007. ,
DOI : 10.1038/nm1538
Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Molecular Cancer, p.71, 2007. ,
Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formylmethionyl-leucyl-phenylalanine-induced chemotaxis, J Immunol, vol.149, pp.989-997, 1992. ,
Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils, Arthritis Research & Therapy, vol.9, issue.2, p.25, 2007. ,
DOI : 10.1186/ar2137
Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption, Blood, vol.114, issue.8, pp.1633-1644, 2009. ,
DOI : 10.1182/blood-2008-09-178301
The role of T cells in the pathogenesis of osteoarthritis, Arthritis & Rheumatism, vol.57, issue.2, pp.409-424, 2007. ,
DOI : 10.1002/art.22369
Evidence that genetic deletion of the TNF receptor p60 or p80 in macrophages modulates RANKL-induced signaling, Blood, vol.104, issue.13, pp.4113-4121, 2004. ,
DOI : 10.1182/blood-2004-04-1607
Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse, The Journal of Experimental Medicine, vol.157, issue.4, pp.877-892, 2009. ,
DOI : 10.4049/jimmunol.168.8.3825
The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis, Arthritis Research & Therapy, vol.8, issue.6, p.187, 2006. ,
DOI : 10.1186/ar2099
Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage, pp.627-635, 2004. ,
DOI : 10.1016/j.joca.2004.03.003
URL : http://doi.org/10.1016/j.joca.2004.03.003